|
U.S. PIRG Consumer Blog
« Recess appointment of industry lobbyist to CPSC? |
Main
| Jet Blue fiasco may spur bill of rights efforts »
February 17, 2007
KEI challenges Rx Giant Gilead on AIDS, avian flu drugs
The leading access to knowledge/access to information advocate known as Knowledge Ecology International (the new home of the Consumer Project on Technology (CPTech)), has filed a complaint with the U.S. Federal Trade Commission (news release) alleging that the pharmaceutical giant Gilead is using anti-competitive practices in efforts to "control global markets for active pharmaceutical ingredients (APIs)." From the Huffington Post blog by KEI's James Love):
Gilead Sciences, the firm chaired by Donald Rumsfeld before he became head of the Department of Defense, was in the news in 2005 over its patents on Tamiflu, a drug used to treat avian flu. More recently, health groups, including ours, are looking closely at efforts by Gilead to control global markets for active pharmaceutical ingredients (APIs) not only for Tamiflu, but also for two AIDS drugs, including one invented at Emory University on government grants.
Posted by Ed Mierzwinski at February 17, 2007 11:23 AM
Post a comment
|
